Ipsen and BioMérieux collaborate in personalised medicine

Ipsen SA and BioMérieux SA of France have entered into a global collaboration to develop therapies and companion diagnostics for prostate and breast cancers, neuro-endocrine tumours and pituitary tumours. Financial terms weren't disclosed.